Drugs Archives - Page 39 of 66 - ��ýҕ�l Health News

KHN’s ‘What The Health?’: Gun Violence And The Politics Of Public Health

The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.

Aug. 8, 2019

Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs

The drug CroFab, which has been on the market since 2000, now faces competition from a drug called Anavip. But both are expensive.

By Carmen Heredia Rodriguez

Aug. 8, 2019

Federal Experts’ Advice On HPV Vaccine Could Leave Adults Confused

A federal advisory panel says people between ages 27 and 45 may benefit from the vaccine to fight the human papillomavirus. But some public health advocates worry that the advice doesn’t provide doctors and patients clear guidance about who in this large age group are good candidates for the vaccine.

By Michelle Andrews

Aug. 8, 2019

Drugmakers Master Rolling Out Their Own Generics To Stifle Competition

Known as “authorized generics,” in-house spinoffs of brand-name drugs quietly undermine the competition.

By Jay Hancock and Sydney Lupkin

Aug. 5, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.

By Brianna Labuskes

Aug. 2, 2019

Bill Of The Month

Infusion Treatments — Needed or Not — Can Deplete Patients’ Wallets

When it comes to physician-administered infusion drugs, doctors sometimes have a financial reason for their choice and patients often aren’t aware of cheaper options.

By Shefali Luthra

Aug. 2, 2019

Podcast

KHN’s ‘What The Health?’: Deciphering The Democrats’ Health Debate

Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHN’s Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.

Aug. 1, 2019

California Bill Would Fight Deals That Delay Generic Drugs

As California Attorney General Xavier Becerra cracks down on pharmaceutical companies he said paid competitors to delay generic versions of their drugs, he’s also pushing for legislation that would give his department tools to catch more of them. It’s the first of its kind in the nation.

By Ana B. Ibarra

Aug. 1, 2019

Trump Administration ‘Open For Business’ On Drug Imports From Canada

HHS secretary announces a preliminary plan Wednesday to allow Americans to import certain lower-cost drugs from Canada. Manufacturers were quick to criticize the plan, saying it does not guarantee the safety of drugs coming into the country.

By Phil Galewitz

July 31, 2019

Trump Administration Moves To Make Health Care Costs More Transparent

The proposed rules would require hospitals to provide far more detail about the actual prices they charge insurers for patients’ care.

By Julie Appleby

July 31, 2019

New Protocol For HIV Prevention Drug Reduces The Number Of Pills Required

Health officials and AIDS advocates in San Francisco have endorsed a new regimen for PrEP medication: to be taken only immediately before and after sex, thus reducing cost and potential side effects. The standard regimen is one pill a day for an open-ended period.

By David Tuller

July 29, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

July 26, 2019

KHN & PolitiFact HealthCheck

Klobuchar Says D.C. Has Enough Drug Lobbyists To Double-Team Lawmakers

The drug industry has the biggest lobbying war chest.

By Julie Appleby

July 26, 2019

GOP Senators Distance Themselves From Grassley And Trump’s Efforts To Cut Drug Prices

Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.

By Emmarie Huetteman

July 25, 2019

Podcast

KHN’s ‘What The Health?’: Cue The Drug Price Debate

Democrats and Republicans on the Senate Finance Committee unveiled their long-awaited proposal to try to rein in prescription drug costs, even as bipartisan leaders of the other Senate committee that oversees health announced it would not bring its drug price bill to the Senate floor until fall. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this, plus court actions on health issues.

July 25, 2019

Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes

Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.

By Emmarie Huetteman

July 24, 2019

KHN & PolitiFact HealthCheck

A Conservative Group Paints Trump’s Drug-Pricing Experiment As ‘Socialist.’ Is It?

The Americans for Tax Reform commercial takes too broad a brush against an initiative under consideration by the administration that would be part of the president’s promise to curb high drug prices.

By Shefali Luthra

July 22, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

July 19, 2019

Podcast

KHN’s ‘What The Health?’: Biden Doubles Down On Obamacare

Presidential candidate Joe Biden unveiled a health plan intended to provide a more moderate alternative to his competitors’ “Medicare for All” plans. It would build on the Affordable Care Act but would go much further. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss this, plus Planned Parenthood’s very bad week, the U.S. House vote to repeal the health law’s “Cadillac tax” on generous health plans, and the reduction in deaths from opioids.

July 18, 2019